Carlo Penzo
@CarloPenzo1
Followers
523
Following
535
Media
9
Statuses
179
Interventional Cardiologist @ Azienda Ospedaliero-Universitaria di Ferrara, MD
Joined May 2015
🇮🇹
pubmed.ncbi.nlm.nih.gov
ClinicalTrials.gov NCT05751577.
TAVI without cardiac surgery on-site in Europe: On march 18, Spanish, Italian, and Polish colleagues, will discuss this major topic during @GACIntervention course @mmamas1973 @Hragy @JeunesGACI @ncurzen @MichaelFabbro1 @sciqst @KardiologieHH @A_Trimaille @BCIS_uk
@JACCJournals
0
6
12
TRACS trial is searching for new solutions... https://t.co/oZ8oVO1tXi
@IannopolloG @G_Tarantini01 @saia_francesco
pubmed.ncbi.nlm.nih.gov
ClinicalTrials.gov NCT05751577.
TAVR is now a mature Tx option. Safety and Efficacy is nothing if patients are not offered the Tx. We have now to redefine TAVR center criteria to deliver the proper care to each patient who deserve it. Equity in care access is a MUST.
0
6
15
In participants with three-vessel CAD from the ISCHEMIA trial, revascularization (either PCI or CABG) was associated with a lower 4-year rate of cardiovascular death or myocardial infarction and improved quality of life. The differences in all-cause mortality were small with wide
7
47
126
Prof @vlgmrc hosted our first #enVast User Meeting. Thanks to Dr @CarloPenzo1 and Dr #MohammadAlkhalil for sharing their experiences and to all participants for their insights! @Diane_Demet @MilziAndrea @dariobongio
1
3
2
🌍 EARTH-STEMI #ESCCongress 🔥 The benefits of complete revascularization now confirmed in older patients with STEMI in an updated IPD meta-analysis 📊 @GianlucaCampo78 @SimoneBiscaglia @escardio @ESC_Journals
#ESC #ESCCongress2024 #Cardiology
1
31
76
Dr @GianlucaCampo78 shares the results from EARTH-STEMI, which showed complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality. Learn more 🔗 https://t.co/iieNGf6mKT 📊Meta-analysis of previous RCTs, including FIRE
0
5
10
🔥🔥🔥 Check out the simultaneous publication on the NSTEMI vs STEMI subanalysis of @theFIRE_trial @JACCJournals 🗣️Consistent benefit of physiology-guided complete revasc in NSTEMI and STEMI patients!
Physiology-guided complete #revascularization may trump culprit-only approaches in older patients suggests #ESCCongress late-breaker: https://t.co/Xkr36F1SpC
#JACC #STEMI #NSTEMI #cvMI
0
22
62
Brilliant as usual
A Little trick to save the radial access for an arterial line after #PCI, thanks to @GianlucaCampo78 for the idea!
0
6
17
@SimoneBiscaglia @GianlucaCampo78 @EAPCIPresident @JEscaned @SerruysPatrick @UretskyBarry Tantissimi auguriii🥳🥳🥳 So well deserved for one of the smartest, kindest, most fun people to work with! A true testament also to the amazing team at @UniFerrara @GianlucaCampo78 @skat_ct @CarloPenzo1 Keep the fire burning 🔥 🔥 🔥
0
3
11
Here we are... the countdown is over and @SimoneBiscaglia showed th3 @theFIRE_trial results... physio-guided complete revasc reduced ☠️ and MI #ESCCongress
2
32
74
In @theFIRE_trial investigators implanted Supraflex Cruz @SMTStents more evidence in challenging scenario is coming... waiting for the results 🗓 Amsterdam @escardio Saturday 26th ⏲️ 4.30PM
In this final report of the TALENT trial, the use of the Supraflex ultrathin strut stent was at least as safe and efficacious as the XIENCE stent at 3 years in an all-comers population. #EAPCI #EIJBestOf. https://t.co/ttWG5oEkQt
0
8
15
In addition, the evidence come from patients aged around 62 years old... and we need RCTs showing how to treat older patients @theFIRE_trial
0
2
5
@theFIRE_trial coming soon from 🇮🇹🇪🇸🇵🇱 to 🌏 Amsterdam Saturday 26th @SimoneBiscaglia @skat_ct @JEscaned @PKardiolog @DrArifK @giuseppe_ando @AntonioMariaLe2 @GraziellaPompei @enrico_cerrato @MilaMenozzi @AndreaSantarel8 @Iginio_Colaiori
0
1
9
Women and older patients.... the missing piece in RCTs.. to fill one of these gaps we designed and conducted the @theFIRE_trial @SimoneBiscaglia
@Barbara_Casadei #RISE2023 How do we get #women into research: 💃🏻 Age: many trials have an upper age limit. Why? 💃🏻need pragmatic trials: women do enroll! 💃🏻two studies separated by 2 decades show women continue to be less likely to recruited! But more likely to drop out too…
0
5
14
This statement of the @escardio Council on Hypertension and the #EAPCI reviews the evidence on renal denervation and provides consensus statements for patient selection, centre requirements, procedural aspects, and considerations for trial design. https://t.co/4EiXl61aTq
2
24
67
The very first patients has been enrolled in the MINOSSE study! 🚩 Can't wait for results ⭐
0
7
15